Breed Reply is an investor in Deep Tech with a focus on AI (Artificial Intelligence) investing across Europe. We provide funding for talented teams with strong AI products that satisfy genuine market needs and have real scalability. We invest in both vertical applications and horizontal platforms.
FoodMarble have developed a breath analysis device called AIRE to help people find the foods that are most compatible with their unique digestive system. Based off an existing clinical trial, AIRE has been created to help the nearly 1 billion people worldwide who suffer from persistent and highly disruptive digestive symptoms.
FoodMarble, the digital digestive health company, has closed a seed investment round of $2.6 million. The round was led by Business Venture Partners (BVP), with participation from Breed Reply, Delta Partners, Enterprise Ireland and SOSV.
Bodytrak is an end-to-end solution that leverages proprietary sensors and algorithms to monitor physiological parameters and provide actionable insights. The key components of the platform are a patented in-ear device offering integrated communications and sensors, and a cloud-based solution providing real-time insights on the physiological state of the user.
WE CURRENTLY HAVE 12 COMPANIES WITHIN THE PORTFOLIO AND EIGHT EXITS IN THE FOLLOWING SECTORS:
Industrial IoT, Health & Wellbeing, Smart Buildings & Cities, Platform Infrastructure and Cyber Security